Semiconductor startup Sophrosyne Technologies has raised $2 million in a seed funding round led by Bluehill.VC.
The company also recently cleared technical diligence and received a MeitY DLI grant of $1.2 million.
The funds will support the transition from prototype silicon to full-scale product development and global OEM engagement. The company will also expand its silicon design and firmware teams and begin early customer deployments in India and international markets.
Co-founded in 2022 by Manish Srivastava and Jatin Gupta, Sophrosyne Technologies is a fabless semiconductor startup based in Bengaluru. The company builds ultra-low power System-on-Chip (SoC) solutions for wearable and digital health devices.
Its architecture integrates biosensing, power management, software support, and AI algorithms into a single chip designed to help device makers offer continuous health monitoring.
The SoC supports multiple physiological signals including ECG, PPG, breathing, and temperature. The platform’s edge and cloud AI models convert raw data into real-time health assessments for timely intervention.